1. Home
  2. MATW vs NRIX Comparison

MATW vs NRIX Comparison

Compare MATW & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATW
  • NRIX
  • Stock Information
  • Founded
  • MATW 1850
  • NRIX 2009
  • Country
  • MATW United States
  • NRIX United States
  • Employees
  • MATW N/A
  • NRIX N/A
  • Industry
  • MATW Metal Fabrications
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATW Telecommunications
  • NRIX Health Care
  • Exchange
  • MATW Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • MATW 721.1M
  • NRIX 750.4M
  • IPO Year
  • MATW 1994
  • NRIX 2020
  • Fundamental
  • Price
  • MATW $23.42
  • NRIX $12.94
  • Analyst Decision
  • MATW
  • NRIX Strong Buy
  • Analyst Count
  • MATW 0
  • NRIX 14
  • Target Price
  • MATW N/A
  • NRIX $26.29
  • AVG Volume (30 Days)
  • MATW 206.3K
  • NRIX 1.9M
  • Earning Date
  • MATW 11-20-2025
  • NRIX 10-09-2025
  • Dividend Yield
  • MATW 4.27%
  • NRIX N/A
  • EPS Growth
  • MATW N/A
  • NRIX N/A
  • EPS
  • MATW N/A
  • NRIX N/A
  • Revenue
  • MATW $1,625,543,000.00
  • NRIX $83,687,000.00
  • Revenue This Year
  • MATW N/A
  • NRIX $58.48
  • Revenue Next Year
  • MATW N/A
  • NRIX N/A
  • P/E Ratio
  • MATW N/A
  • NRIX N/A
  • Revenue Growth
  • MATW N/A
  • NRIX 48.32
  • 52 Week Low
  • MATW $18.50
  • NRIX $8.18
  • 52 Week High
  • MATW $32.24
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • MATW 48.04
  • NRIX 70.14
  • Support Level
  • MATW $22.63
  • NRIX $11.37
  • Resistance Level
  • MATW $23.49
  • NRIX $13.24
  • Average True Range (ATR)
  • MATW 0.58
  • NRIX 0.83
  • MACD
  • MATW 0.05
  • NRIX 0.28
  • Stochastic Oscillator
  • MATW 71.71
  • NRIX 92.80

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: